• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[复发性显著菌尿与IgA肾病的进展]

[Recurrent significant bacteriuria and progression of IgA nephropathy].

作者信息

Vas T, Kovács T, Kocsis B, Nagy J

机构信息

Pćsi Orvostudományi Egyetem, II. Belgyógyászati Klinika, Nephrológiai Centrum.

出版信息

Orv Hetil. 1998 Feb 15;139(7):349-52.

PMID:9501671
Abstract

Tubulointerstitial changes seems to be of decisive importance among factors influencing the prognosis of IgA nephropathy. In consequence of decreased protection ability of mucous membranes, in some cases masked urinary tract infections may stand in the background of the tubulointerstitial changes. In this study the connection between urinary tract infections, significant bacteriurias and the progression of IgA nephropathy was retrospectively investigated. The data and the progress of the disease of 19 IgA nephropathy patients with significant bacteriuria (microbiologically identified) were compared to 19 IgA nephropathy patients of similar age, sex and the time of follow-up without bacteriuria. During the follow-up (on the average 8.5 years), the renal function (values of serum creatinine) decreased significantly (p < 0.05) in both groups, but there was no significant difference between the two groups. Neither at start, nor at the end of the follow-up no significant difference was found in the two groups in the prevalence of proteinuria, haematuria, hypertension and between the values of serum parameters. On the basis of these data we assume, that with the help of frequent medical check up and adequate antibiotic treatment the unfavourable effects of urinary tract infections (chronic tubulointerstitial changes) can probably be fended off.

摘要

在影响IgA肾病预后的诸多因素中,肾小管间质改变似乎起着决定性作用。由于黏膜保护能力下降,在某些情况下,隐匿性尿路感染可能是肾小管间质改变的潜在原因。本研究对尿路感染、显著菌尿与IgA肾病进展之间的关系进行了回顾性调查。将19例有显著菌尿(经微生物学鉴定)的IgA肾病患者的数据及疾病进展情况,与19例年龄、性别及随访时间相似但无菌尿的IgA肾病患者进行比较。在随访期间(平均8.5年),两组的肾功能(血清肌酐值)均显著下降(p<0.05),但两组之间无显著差异。在随访开始时和结束时,两组在蛋白尿、血尿、高血压的发生率及血清参数值方面均未发现显著差异。基于这些数据我们推测,通过频繁体检和适当的抗生素治疗,或许可以抵御尿路感染(慢性肾小管间质改变)的不利影响。

相似文献

1
[Recurrent significant bacteriuria and progression of IgA nephropathy].[复发性显著菌尿与IgA肾病的进展]
Orv Hetil. 1998 Feb 15;139(7):349-52.
2
A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.IgA肾病肾脏存活的一种新型更简单组织学分类:一项回顾性研究。
Am J Kidney Dis. 2007 Jun;49(6):763-75. doi: 10.1053/j.ajkd.2007.03.013.
3
Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.IgA 肾病高血压患者血压降低与肾功能保留的相关性:一项 3 年随访研究
Clin Nephrol. 2000 Nov;54(5):360-5.
4
Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy.高血压及高血压相关血管病变在IgA肾病中的影响
Hypertens Res. 2006 Jan;29(1):15-22. doi: 10.1291/hypres.29.15.
5
Proteinuria in IgA nephropathy.IgA肾病中的蛋白尿
Semin Nephrol. 1987 Dec;7(4):344-5.
6
Natural history of IgA nephropathy in patients followed-up for more than ten years in Spain.西班牙对IgA肾病患者进行超过十年随访的自然病史。
Semin Nephrol. 1987 Dec;7(4):346-50.
7
Clinical features and natural history of IgA nephropathy.IgA肾病的临床特征与自然病程。
Ann Med Interne (Paris). 1999 Feb;150(2):117-26.
8
The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.血管紧张素转换酶基因多态性对马来西亚患者免疫球蛋白A肾病进展的影响。
Singapore Med J. 2008 Nov;49(11):924-9.
9
Increase in proteinuria and/or microhematuria following upper respiratory tract infections in patients with IgA nephropathy.IgA肾病患者上呼吸道感染后蛋白尿和/或微量血尿增加。
Tokai J Exp Clin Med. 1984 Jun;9(2):139-45.
10
[IgA nephropathy in patients above 45 years of age. Clinical and morphologic analysis].[45岁以上患者的IgA肾病。临床与形态学分析]
Pol Merkur Lekarski. 1997 Sep;3(15):115-8.